DNAprint Genomics (DNAG)

[worktoplay]

eb0783/gcbr...Boy do I wish I had been able to attend the meeting. lol

I would have asked the obvious follow-up that no one seems to have considered, and it's the reason I posted that text from the Moffitt Agreement.

The question is, if DNAPrint will be starting clinical trials on a total of 24 drugs in September, how is that going to be paid for??? CERTAINLY, DNAPrint is not in a financial position to support TWENTY FOUR clinical trials. Heck, I remember the 10K talking about needing $250K just to do the Ovanome trial if necessary.

So I see one of two possible scenarios:

1) They're going to be coming into the money to support the trials - doubtful IMO

2) The Principal Investigators (perhaps with some support from DNAP or another third party) are going to provide the funding.

And in the second case, the next question becomes will we be generating revenues from genotyping and running our platform?

That's what I meant...lol

Later,
W2P